Cargando…

Development and optimization of targeted radionuclide tumor therapy using folate based radiopharmaceuticals

The folate receptor (FR) has been used for a quarter of a century as a tumor-associated target for selective delivery of drugs and imaging agents to cancer cells. While several folic acid radioconjugates have been successfully employed for imaging purposes in (pre)clinical studies, a therapeutic app...

Descripción completa

Detalles Bibliográficos
Autor principal: Reber, Josefine Astrid
Lenguaje:eng
Publicado: 2015
Materias:
Acceso en línea:http://cds.cern.ch/record/2063482

Ejemplares similares